Etiology and management of early pregnancy renal anhydramnios: Is there a place for serial amnioinfusions?
- PMID: 32003482
- PMCID: PMC7780162
- DOI: 10.1002/pd.5658
Etiology and management of early pregnancy renal anhydramnios: Is there a place for serial amnioinfusions?
Abstract
Early pregnancy renal anhydramios (EPRA) comprises congenital renal disease that results in fetal anhydramnios by 22 weeks of gestation. It occurs in over 1 in 2000 pregnancies and affects 1500 families in the US annually. EPRA was historically considered universally fatal due to associated pulmonary hypoplasia and neonatal respiratory failure. There are several etiologies of fetal renal failure that result in EPRA including bilateral renal agenesis, cystic kidney disease, and lower urinary tract obstruction. Appropriate sonographic evaluation is required to arrive at the appropriate urogenital diagnosis and to identify additional anomalies that allude to a specific genetic diagnosis. Genetic evaluation variably includes karyotype, microarray, targeted gene testing, panels, or whole exome sequencing depending on presentation. Patients receiving a fetal diagnosis of EPRA should be offered management options of pregnancy termination or perinatal palliative care, with the option of serial amnioinfusion therapy offered on a research basis. Preliminary data from case reports demonstrate an association between serial amnioinfusion therapy and short-term postnatal survival of EPRA, with excellent respiratory function in the neonatal period. A multicenter trial, the renal anhydramnios fetal therapy (RAFT) trial, is underway. We sought to review the initial diagnosis ultrasound findings, genetic etiologies, and current management options for EPRA.
© 2020 John Wiley & Sons, Ltd.
Conflict of interest statement
CONFLICT OF INTEREST
The authors declare no conflict of interest.
Figures
References
-
- Ruano R, Safdar A, Au J, et al. Defining and predicting ‘intrauterine fetal renal failure’ in congenital lower urinary tract obstruction. Pediatr Nephrol Berl Ger. 2016;31(4):605–612. - PubMed
-
- Balasundaram M, Chock VY, Wu HY, Blumenfeld YJ, Hintz SR. Predictors of poor neonatal outcomes in prenatally diagnosed multicystic dysplastic kidney disease. J Perinatol Off J Calif Perinat Assoc. 2018;38(6):658–664. - PubMed
-
- Adzick NS, Harrison MR, Glick PL, Villa RL, Finkbeiner W. Experimental pulmonary hypoplasia and oligohydramnios: relative contributions of lung fluid and fetal breathing movements. J Pediatr Surg. 1984;19(6):658–665. - PubMed
-
- Kitterman JA. The effects of mechanical forces on fetal lung growth. Clin Perinatol. 1996;23(4):727–740. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
